Literature DB >> 6787175

Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.

D D Schoepp, A J Azzaro.   

Abstract

Studies were designed to evaluate specificity of the transmitter amines serotonin (5-hydroxytryptamine, 5-HT) and dopamine (DA), as well as the trace amines p-tyramine (p-TA) and beta-phenylethylamine (PEA) for types A and B monoamine oxidase (MAO) in rat striatum. 5-HT was found to be a specific substrate for the type A enzyme. However, the specificity of PEA for the type B enzyme was found to be concentration-dependent. When low concentrations of PEA and 5-HT were used to measure type B and type A activities, respectively, both clorgyline and deprenyl were highly selective for the sensitive form of MAO in vivo. However, as the concentration of PEA was increased, the type B inhibitor deprenyl became less effective in preventing deamination of PEA. Conversely, the type A inhibitor clorgyline became more effective in this regard. Kinetic analysis following selective in vivo inhibition showed PEA deamination by both forms of MAO with a 13-fold greater affinity for the type B enzyme. In vivo dose-response curves obtained with the common substrates DA and p-TA showed approximately 20% deamination by the B enzyme. Kinetic values for DA and p-TA deamination in in vivo-treated tissue possessing only type A or type B MAO activity, revealed a 2.5-fold greater affinity for the type A enzyme. These studies show the importance of concentration on substrate specificity in striatal tissue. The results obtained characterize the common substrate properties of DA and p-TA as well as of PEA in rat striatum. In addition, the presence of regional specificity for 5-HT deamination by only type A MAO is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787175     DOI: 10.1111/j.1471-4159.1981.tb10829.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

Authors:  Joseph M Breier; Michael G Bankson; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

2.  In vivo labelling and axonal transport of monoamine oxidase in the rat basal ganglia using radioactive pargyline.

Authors:  J B Gramsbergen; J B Sebens; J Korf
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.

Authors:  A J Azzaro; J B Amedro; L M Brown; D J Smith; G M Williams
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

Review 4.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

5.  Dopa decarboxylase activity of the living human brain.

Authors:  A Gjedde; J Reith; S Dyve; G Léger; M Guttman; M Diksic; A Evans; H Kuwabara
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.

Authors:  I A Paterson; B A Davis; D A Durden; A V Juorio; P H Yu; G Ivy; W Milgram; A Mendonca; P Wu; A A Boulton
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

7.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

8.  Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.

Authors:  F Molina-Holgado; E Molina-Holgado; M L Leret; M I González; T A Reader
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

9.  Inhibition of rat brain monoamine oxidase type A by 2-aminotetralin and tetrahydroisoquinoline analogues of dopamine.

Authors:  M G Feenstra; T van der Velden; D Dijkstra; O R Hommes; A S Horn
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

10.  Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.

Authors:  William F Maragos; Kristie L Young; Chris S Altman; Chava B Pocernich; Jennifer Drake; D Allan Butterfield; Isabelle Seif; Daniel P Holschneider; Kevin Chen; Jean C Shih
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.